Association between insulin resistance and the development of cardiovascular disease
Связь между инсулинорезистентностью и развитием сердечно-сосудистых заболеваний
2018-08-31
SCID: 54.1/gww6deed
Discuss with AI
cardiovascular diseasedyslipidemiaendothelial dysfunctioninsulin resistancemyocardial metabolism
Figures from the paper
Abstract (AI)
For many years, cardiovascular disease (CVD) has been the leading cause of death around the world. Often associated with CVD are comorbidities such as obesity, abnormal lipid profiles and insulin resistance. Insulin is a key hormone that functions as a regulator of cellular metabolism in many tissues in the human body. Insulin resistance is defined as a decrease in tissue response to insulin stimulation thus insulin resistance is characterized by defects in uptake and oxidation of glucose, a decrease in glycogen synthesis, and, to a lesser extent, the ability to suppress lipid oxidation. Literature widely suggests that free fatty acids are the predominant substrate used in the adult myocardium for ATP production, however, the cardiac metabolic network is highly flexible and can use other substrates, such as glucose, lactate or amino acids. During insulin resistance, several metabolic alterations induce the development of cardiovascular disease. For instance, insulin resistance can induce an imbalance in glucose metabolism that generates chronic hyperglycemia, which in turn triggers oxidative stress and causes an inflammatory response that leads to cell damage. Insulin resistance can also alter systemic lipid metabolism which then leads to the development of dyslipidemia and the well-known lipid triad: (1) high levels of plasma triglycerides, (2) low levels of high-density lipoprotein, and (3) the appearance of small dense low-density lipoproteins. This triad, along with endothelial dysfunction, which can also be induced by aberrant insulin signaling, contribute to atherosclerotic plaque formation. Regarding the systemic consequences associated with insulin resistance and the metabolic cardiac alterations, it can be concluded that insulin resistance in the myocardium generates damage by at least three different mechanisms: (1) signal transduction alteration, (2) impaired regulation of substrate metabolism, and (3) altered delivery of substrates to the myocardium. The aim of this review is to discuss the mechanisms associated with insulin resistance and the development of CVD. New therapies focused on decreasing insulin resistance may contribute to a decrease in both CVD and atherosclerotic plaque generation.
Key Findings
1
Dyslipidemia and insulin-signaling-related endothelial dysfunction contribute to atherosclerotic plaque formation.
2
Impaired insulin-stimulated glucose uptake, oxidation, and glycogen synthesis can produce chronic hyperglycemia, oxidative stress, inflammation, and cellular injury.
3
Insulin resistance is associated with cardiovascular disease through disrupted glucose and lipid metabolism, endothelial dysfunction, and inflammatory damage.
4
Insulin resistance promotes dyslipidemia characterized by high plasma triglycerides, low high-density lipoprotein, and small dense low-density lipoproteins.
5
Myocardial insulin resistance damages the heart through altered signal transduction, impaired substrate-metabolism regulation, and abnormal substrate delivery.
Research Object
Insulin resistance in the myocardium and cardiovascular system
Research Subject
Metabolic and signaling alterations through which insulin resistance promotes cardiovascular disease, including impaired substrate metabolism, dyslipidemia, oxidative stress, inflammation, endothelial dysfunction, and atherosclerotic plaque formation
Publication Details
Publication Date
2018-08-31
Journal
Publisher
ISSN
Cited by
2433
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by5
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes2020
Trends in insulin resistance: insights into mechanisms and therapeutic strategy2022
Pediatric Obesity: Complications and Current Day Management2023
Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions2024
Tissue-specific activation of insulin signaling as a potential target for obesity-related metabolic disorders2024